Keyphrases
3D Perspective
32%
Advanced Statistics
32%
Antidepressants
32%
Antipsychotics
21%
Bayesian Analysis
32%
Bayesian Hypothesis Testing
32%
Bayesian Statistics
32%
Beck Depression inventory-II (BDI-II)
32%
Children on the Autism Spectrum
32%
Chronic Fatigue Syndrome
64%
Cluster Evaluation
21%
Co-occurring Psychiatric Symptoms
32%
Course Trajectory
32%
Depressive Symptoms
25%
Differential Item Functioning
32%
Ecological Momentary Assessment
32%
Equivalent Design
32%
Evidential Strength
32%
Familial Coaggregation
32%
Familiality
32%
Fibromyalgia
42%
Functional Disorders
32%
Functional Somatic Syndromes
100%
Internalizing Disorders
32%
Irritable Bowel Syndrome
39%
Item Response Theory
32%
Long-term Depression
32%
Machine Learing
32%
Major Depressive Disorder
45%
Medical Statistics
32%
Myalgic Encephalomyelitis/chronic Fatigue Syndrome (ME/CFS)
49%
New Onset
32%
Patient-tailored
32%
Perpetuating Factors
32%
Personalised Assessment
32%
Primary Care
44%
Primary Care Patients
38%
Principal Component Model
32%
Self-help
32%
Self-help Intervention
32%
Simultaneous Decomposition
32%
Somatic Symptom Severity
20%
Somatic Symptoms
40%
Somatization
26%
Specific Course
32%
Strength of Evidence
42%
Symptom Measurement
32%
Three-mode
32%
Three-mode Principal Component Analysis
25%
Treatment Effect
32%
Medicine and Dentistry
Antidepressant
64%
Anxiety Disorder
32%
Arm
10%
Beck Depression Inventory
32%
Bupropion
24%
Chronic Fatigue Syndrome
32%
Citalopram
8%
Clinical Trial
40%
Depression
9%
Desvenlafaxine
8%
Drug Efficacy
21%
Duloxetine
8%
Effect Size
32%
Escitalopram
8%
Fibromyalgia
32%
Fluoxetine
8%
Irritable Bowel Syndrome
32%
Logistic Regression Analysis
8%
Long-Term Depression
32%
Major Depressive Episode
38%
Medical Statistics
32%
Medicine
32%
Meta-Analysis
32%
Milnacipran
8%
Mirtazapine
8%
Mixture Model
6%
Nefazodone
8%
Outpatient
6%
Paroxetine
24%
Placebo
32%
Primary Health Care
38%
Principal Component Analysis
25%
Prognostic Factor
10%
Randomized Controlled Trial
6%
Research Design
32%
Second-Generation Antidepressant
42%
Sertraline
8%
Somatics
48%
Symptom
65%
Symptomatology
13%
Treatment of Depression
32%
Venlafaxine
24%
Vilazodone
24%
Vortioxetine
8%
Psychology
Attention Deficit Hyperactivity Disorder
32%
Beck Depression Inventory
40%
Chronic Disorder
32%
Cognitive Behavior Therapy
32%
Comorbidity
8%
Demographic Variable
8%
Depression
70%
Depression
10%
Discrimination
32%
Early Intervention
32%
Etiology of Depression
8%
Evidence-Based Treatment
32%
Externalization
32%
Fibromyalgia
32%
Gender Influence
6%
Gender Role
6%
Internalizing
21%
Irritable Bowel Syndrome
32%
Latent Class Growth Analyses
10%
Loneliness
5%
Long-Term Outcome
5%
Major Depression
8%
Mental Health
5%
Meta-Analysis
32%
Mixture Model
6%
Mood
32%
Multi-Level Modeling
32%
Multinomial Logistic Regression
10%
Neuroticism
13%
Principal Component Analysis
57%
Prognostic Model
18%
Psychology
32%
Quality of Life
45%
Self-Esteem
13%
Somatization
69%
Statistical Analysis
32%
